UBRIGENE
Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.
UBRIGENE
Industry:
Biotechnology
Founded:
2015-01-01
Website Url:
http://www.ubrigene.com
Status:
Active
Total Funding:
200 M CNY
Technology used in webpage:
SPF HiChina DNS China Unicom
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
RootPath Genomics
RootPath Genomics is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
Current Employees Featured
Founder
Investors List
Ming Bioventures
Ming Bioventures investment in Series B - Ubrigene
Cowin Capital
Cowin Capital investment in Series B - Ubrigene
IDG Capital
IDG Capital investment in Series B - Ubrigene
FOF Capital
FOF Capital investment in Series B - Ubrigene
Addor Capital
Addor Capital investment in Series B - Ubrigene
Official Site Inspections
http://www.ubrigene.com
- Host name: ec2-54-219-239-177.us-west-1.compute.amazonaws.com
- IP address: 54.219.239.177
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
